Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion type Assertion NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_head.
- NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion description "[Proliferative vitreoretinopathy vitreous stimulated the production of chemokine (C-C motif) ligand (CCL)2, chemokine (C-X-C motif) ligand (CXCL)8, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-6, and platelet-derived growth factor (PDGF)-BB by ARPE-19 to significantly (P < 0.05) higher levels than vitreous from the RRD1 and RRD2 groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_provenance.
- NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion evidence source_evidence_literature NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_provenance.
- NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion SIO_000772 25015355 NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_provenance.
- NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion wasDerivedFrom befree-2016 NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_provenance.
- NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_assertion wasGeneratedBy ECO_0000203 NP1200661.RA-M1X0Kpou0SaAoWy7szzCPZo5SrmMuBgQhWh8-bXtvM130_provenance.